Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy. [electronic resource]
- The journal of supportive oncology May 2006
- 243-50 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1544-6794
Adenocarcinoma--drug therapy Adult Anemia--chemically induced Antineoplastic Agents--adverse effects Clinical Trials as Topic Colorectal Neoplasms--drug therapy Epoetin Alfa Erythropoietin--therapeutic use Fatigue--etiology Hemoglobins--analysis Humans Quality of Life Recombinant Proteins Retrospective Studies